OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
David C. Wheeler, June James, Dipesh Patel, et al.
Diabetes Therapy (2020) Vol. 11, Iss. 12, pp. 2757-2774
Open Access | Times Cited: 31
David C. Wheeler, June James, Dipesh Patel, et al.
Diabetes Therapy (2020) Vol. 11, Iss. 12, pp. 2757-2774
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
David C. Wheeler, Bergur V. Stefánsson, Niels Jongs, et al.
The Lancet Diabetes & Endocrinology (2020) Vol. 9, Iss. 1, pp. 22-31
Open Access | Times Cited: 409
David C. Wheeler, Bergur V. Stefánsson, Niels Jongs, et al.
The Lancet Diabetes & Endocrinology (2020) Vol. 9, Iss. 1, pp. 22-31
Open Access | Times Cited: 409
Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial
Jens Christian Laursen, Niels Søndergaard Heinrich, Joana Mendes Lopes de Melo, et al.
EClinicalMedicine (2021) Vol. 37, pp. 100895-100895
Open Access | Times Cited: 63
Jens Christian Laursen, Niels Søndergaard Heinrich, Joana Mendes Lopes de Melo, et al.
EClinicalMedicine (2021) Vol. 37, pp. 100895-100895
Open Access | Times Cited: 63
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
Samuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1099-1124
Open Access | Times Cited: 8
Samuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1099-1124
Open Access | Times Cited: 8
The effect of periodic resistance training on obese patients with type 2 diabetic nephropathy
Sumei Li, Shouping Yuan, Jintian Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Sumei Li, Shouping Yuan, Jintian Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice
Bernt Johan von Scholten, Frederik Flindt Kreiner, Søren Rasmussen, et al.
Therapeutic Advances in Endocrinology and Metabolism (2022) Vol. 13
Open Access | Times Cited: 23
Bernt Johan von Scholten, Frederik Flindt Kreiner, Søren Rasmussen, et al.
Therapeutic Advances in Endocrinology and Metabolism (2022) Vol. 13
Open Access | Times Cited: 23
Management of chronic kidney disease in type 2 diabetes: screening, diagnosis and treatment goals, and recommendations
Jay H. Shubrook, Joshua J. Neumiller, Eugene E. Wright
Postgraduate Medicine (2021) Vol. 134, Iss. 4, pp. 376-387
Open Access | Times Cited: 30
Jay H. Shubrook, Joshua J. Neumiller, Eugene E. Wright
Postgraduate Medicine (2021) Vol. 134, Iss. 4, pp. 376-387
Open Access | Times Cited: 30
SGLT2 inhibitors in hypertension: Role beyond diabetes and heart failure
Rahul Gupta, Theresa Maitz, David Egeler, et al.
Trends in Cardiovascular Medicine (2022) Vol. 33, Iss. 8, pp. 479-486
Closed Access | Times Cited: 20
Rahul Gupta, Theresa Maitz, David Egeler, et al.
Trends in Cardiovascular Medicine (2022) Vol. 33, Iss. 8, pp. 479-486
Closed Access | Times Cited: 20
Myocardial Revascularization in Patients with Diabetes and Heart Failure—A Narrative Review
Stefan Zivkovic, Aleksandar Mandić, Kosta Krupniković, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3398-3398
Open Access
Stefan Zivkovic, Aleksandar Mandić, Kosta Krupniković, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3398-3398
Open Access
Association of platelet-to-lymphocyte ratio with kidney clinicopathologic features and renal outcomes in patients with diabetic kidney disease
Suyan Duan, Lianqin Sun, Chengning Zhang, et al.
International Immunopharmacology (2021) Vol. 93, pp. 107413-107413
Closed Access | Times Cited: 24
Suyan Duan, Lianqin Sun, Chengning Zhang, et al.
International Immunopharmacology (2021) Vol. 93, pp. 107413-107413
Closed Access | Times Cited: 24
The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review
John Wilding, Marc Evans, Kevin Fernando, et al.
Diabetes Therapy (2022) Vol. 13, Iss. 5, pp. 847-872
Open Access | Times Cited: 17
John Wilding, Marc Evans, Kevin Fernando, et al.
Diabetes Therapy (2022) Vol. 13, Iss. 5, pp. 847-872
Open Access | Times Cited: 17
Perspectives on the Role of Magnetic Resonance Imaging (MRI) for Noninvasive Evaluation of Diabetic Kidney Disease
José María Mora‐Gutiérrez, María A. Fernández‐Seara, Rebeca Echeverría‐Chasco, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2461-2461
Open Access | Times Cited: 22
José María Mora‐Gutiérrez, María A. Fernández‐Seara, Rebeca Echeverría‐Chasco, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2461-2461
Open Access | Times Cited: 22
CHOP-ASO Ameliorates Glomerular and Tubular Damage on Top of ACE Inhibition in Diabetic Kidney Disease
Khurrum Shahzad, Sameen Fatima, Moh’d Mohanad Al‐Dabet, et al.
Journal of the American Society of Nephrology (2021) Vol. 32, Iss. 12, pp. 3066-3079
Open Access | Times Cited: 22
Khurrum Shahzad, Sameen Fatima, Moh’d Mohanad Al‐Dabet, et al.
Journal of the American Society of Nephrology (2021) Vol. 32, Iss. 12, pp. 3066-3079
Open Access | Times Cited: 22
NEW DIRECTIONS IN PHARMACOLOGICAL TREATMENT WITH SGLT-2 INHIBITOR MOLECULES IN THE LIGHT OF CURRENT GUIDELINES FOR DIABETES MELLITUS, HEART FAILURE AND KIDNEY DISEASE
Mariana Cornelia Tilinca
FARMACIA (2023) Vol. 71, Iss. 4, pp. 686-696
Open Access | Times Cited: 8
Mariana Cornelia Tilinca
FARMACIA (2023) Vol. 71, Iss. 4, pp. 686-696
Open Access | Times Cited: 8
Characteristics of patients with chronic kidney disease and Type 2 diabetes initiating finerenone in the USA: a multi-database, cross-sectional study
David Vizcaya, Csaba P. Kövesdy, Andrés Reyes, et al.
Journal of Comparative Effectiveness Research (2023) Vol. 12, Iss. 8
Open Access | Times Cited: 6
David Vizcaya, Csaba P. Kövesdy, Andrés Reyes, et al.
Journal of Comparative Effectiveness Research (2023) Vol. 12, Iss. 8
Open Access | Times Cited: 6
The impact of SGLT2 inhibitors on αKlotho in renal MDCK and HK-2 cells
Lisa Wolf, Michael Föller, Martina Feger
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3
Lisa Wolf, Michael Föller, Martina Feger
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3
The efficacy and safety of dapagliflozin combined with oral hypoglycemic agents in patients with type 2 diabetes: a systematic review and meta-analysis
Xuezhong Xu, Wen Xu, Qingqing Zhuo, et al.
Annals of Palliative Medicine (2022) Vol. 11, Iss. 3, pp. 1028-1037
Open Access | Times Cited: 5
Xuezhong Xu, Wen Xu, Qingqing Zhuo, et al.
Annals of Palliative Medicine (2022) Vol. 11, Iss. 3, pp. 1028-1037
Open Access | Times Cited: 5
Real-World Evaluation of Demographics, Treatment Pattern, and Economic Burden of Heart Failure and Kidney Disease in Type 2 Diabetes Mellitus Patient Population in Dubai, United Arab Emirates
Alaaeldin Bashier, Mohamed Farghaly, Juwairia Alali, et al.
Dubai Diabetes and Endocrinology Journal (2023) Vol. 29, Iss. 1, pp. 42-54
Open Access | Times Cited: 2
Alaaeldin Bashier, Mohamed Farghaly, Juwairia Alali, et al.
Dubai Diabetes and Endocrinology Journal (2023) Vol. 29, Iss. 1, pp. 42-54
Open Access | Times Cited: 2
Investigating patients’ preferences for new anti-diabetic drugs to inform public health insurance coverage decisions: a discrete choice experiment in China
Jinsong Geng, Haini Bao, Zhe Feng, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Jinsong Geng, Haini Bao, Zhe Feng, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Glycemic Variability in Different Stages of Chronic Kidney Disease with Type 2 Diabetes Mellitus: A Cross-sectional Study
Sapna Gupta, Nivedita Priya
Indian Journal of Medical Biochemistry (2024) Vol. 28, Iss. 1, pp. 1-7
Open Access
Sapna Gupta, Nivedita Priya
Indian Journal of Medical Biochemistry (2024) Vol. 28, Iss. 1, pp. 1-7
Open Access
Global, Regional, and National Burden of Chronic Kidney Disease in Older Adults from 1990 to 2021: Results from the Global Burden of Disease Study 2021
Weixuan Wang, Junhui Wu, Shaomei Shang
(2024)
Closed Access
Weixuan Wang, Junhui Wu, Shaomei Shang
(2024)
Closed Access
Novel Hits for Targeting Kidney Failure in Type 2 Diabetes derived via In Silico Screening of the ZINC Natural Product Database
Neda Shakour, Saeideh Hoseinpoor, Saghi Sepehri, et al.
Journal of Computational Science (2024) Vol. 85, pp. 102497-102497
Closed Access
Neda Shakour, Saeideh Hoseinpoor, Saghi Sepehri, et al.
Journal of Computational Science (2024) Vol. 85, pp. 102497-102497
Closed Access
Effect of Sodium-Glucose Co-Transporter 2 Inhibitors on MCP-1 and Uromodulin Levels in Patients with Type 2 Diabetes Mellitus
M.A. Pathak, Haya Majid, P. Meera Khan, et al.
Clinical Epidemiology and Global Health (2024), pp. 101888-101888
Open Access
M.A. Pathak, Haya Majid, P. Meera Khan, et al.
Clinical Epidemiology and Global Health (2024), pp. 101888-101888
Open Access
Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
Jingjing Zhou, Shimin Jiang, Zhongxin Li, et al.
Diabetes Therapy (2023) Vol. 14, Iss. 3, pp. 497-506
Open Access | Times Cited: 1
Jingjing Zhou, Shimin Jiang, Zhongxin Li, et al.
Diabetes Therapy (2023) Vol. 14, Iss. 3, pp. 497-506
Open Access | Times Cited: 1
The effect of periodic resistance training on obese patients with type 2 diabetic nephropathy
Sumei Li, Shouping Yuan, Jintian Zhang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Sumei Li, Shouping Yuan, Jintian Zhang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
